A detailed history of Capital Group Private Client Services, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Capital Group Private Client Services, Inc. holds 484,763 shares of AZN stock, worth $30.6 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
484,763
Previous 495,296 2.13%
Holding current value
$30.6 Million
Previous $38.6 Million 2.22%
% of portfolio
0.38%
Previous 0.4%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$76.67 - $87.62 $807,565 - $922,901
-10,533 Reduced 2.13%
484,763 $37.8 Million
Q2 2024

Aug 13, 2024

SELL
$66.81 - $80.83 $2.6 Million - $3.15 Million
-38,946 Reduced 7.29%
495,296 $38.6 Million
Q1 2024

May 14, 2024

SELL
$61.03 - $69.57 $2.97 Million - $3.39 Million
-48,666 Reduced 8.35%
534,242 $36.2 Million
Q4 2023

Feb 13, 2024

SELL
$61.89 - $69.28 $5.49 Million - $6.14 Million
-88,668 Reduced 13.2%
582,908 $39.3 Million
Q3 2023

Nov 13, 2023

SELL
$64.85 - $71.7 $320,359 - $354,198
-4,940 Reduced 0.73%
671,576 $45.5 Million
Q2 2023

Aug 11, 2023

SELL
$69.91 - $75.81 $335,917 - $364,267
-4,805 Reduced 0.71%
676,516 $48.4 Million
Q1 2023

May 15, 2023

SELL
$63.15 - $71.6 $239,275 - $271,292
-3,789 Reduced 0.55%
681,321 $47.3 Million
Q4 2022

Feb 14, 2023

BUY
$54.21 - $70.44 $178,079 - $231,395
3,285 Added 0.48%
685,110 $46.5 Million
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $509,893 - $1.31 Million
-9,617 Reduced 1.39%
681,825 $37.4 Million
Q2 2022

Aug 15, 2022

BUY
$59.26 - $71.14 $2.46 Million - $2.95 Million
41,459 Added 6.38%
691,442 $45.7 Million
Q1 2022

May 16, 2022

BUY
$55.72 - $67.12 $574,473 - $692,007
10,310 Added 1.61%
649,983 $43.1 Million
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $654,290 - $773,108
-12,112 Reduced 1.86%
639,673 $37.3 Million
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $36.2 Million - $39.6 Million
651,785 New
651,785 $39.1 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $196B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Capital Group Private Client Services, Inc. Portfolio

Follow Capital Group Private Client Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Private Client Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Private Client Services, Inc. with notifications on news.